Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

713 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
Zhuang Q, Liao A, He Q, Liu C, Zheng C, Li X, Liu Y, Wang B, Liu S, Zhang Y, Lin R, Chen H, Deng M, Tang Y, He C, Dai W, Tang H, Gong L, Li L, Xu B, Yang C, Zhou B, Su D, Guo Q, Li B, Zhou Y, Wang X, Fei S, Wu H, Wei S, Peng Z, Wang J, Li Y, Wang H, Deng T, Ding S, Li F, Chen M, Xiao Y. Zhuang Q, et al. Among authors: liao a. J Gastroenterol Hepatol. 2024 Apr;39(4):658-666. doi: 10.1111/jgh.16471. Epub 2024 Jan 22. J Gastroenterol Hepatol. 2024. PMID: 38251791 Clinical Trial.
Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial.
Tan ND, Miao XP, Liao AJ, Liu CX, Wu H, Chen HH, Li FF, Guo QH, Li SB, Tang YP, Xia M, Liu YL, Li X, Chen HX, Liu XW, Zhang Y, Zhang ZY, Chen MH, Xiao YL. Tan ND, et al. Clin Transl Gastroenterol. 2023 Jul 1;14(7):e00602. doi: 10.14309/ctg.0000000000000602. Clin Transl Gastroenterol. 2023. PMID: 37235793 Free PMC article. Clinical Trial.
The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial.
Tan N, Wu H, Lan C, Liu C, Liao A, Jiao Z, Su D, Zhang X, Zhang Z, Xiao W, Li F, Li X, Xia M, Qiu R, Chen H, Liu Y, Su M, Chen M, Xiao Y. Tan N, et al. Among authors: liao a. Int J Antimicrob Agents. 2024 Nov;64(5):107320. doi: 10.1016/j.ijantimicag.2024.107320. Epub 2024 Sep 16. Int J Antimicrob Agents. 2024. PMID: 39293772 Free article. Clinical Trial.
713 results